Journal Article (Letter) DZNE-2024-01382

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Divisions over the regulation of lecanemab.

 ;  ;  ;

2024
Elsevier London [u.a.]

The lancet 404(10468), 2160 - 2161 () [10.1016/S0140-6736(24)02513-3]

This record in other databases:    

Please use a persistent id in citations: doi:

Classification:

Contributing Institute(s):
  1. Molecular Neurodegeneration (AG Haass)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2024
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 90 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > M DZNE > M DZNE-AG Haass
Public records
Publications Database

 Record created 2024-12-02, last modified 2024-12-08


Fulltext:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)